Onconetix, Inc. Additional Collateral, Aggregate Fair Value
Onconetix, Inc. (ONCO) had Additional Collateral, Aggregate Fair Value of $33.50 thousand as of 2023-03-31, per its 10-Q filed 2024-05-20.
Discontinued › Notes › Derivative Instruments and Hedging Activities › Summary of Derivative Instruments
us-gaap:AdditionalCollateralAggregateFairValue · last filed 2024-05-20
- 2023-03-31: Additional Collateral, Aggregate Fair Value $33.50K.
| Period end | Additional Collateral, Aggregate Fair Value |
|---|---|
| 2023-03-31 | $33.50K 10-Q · filed 2024-05-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |